Eyevensys

About:

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

Website: http://www.eyevensys.com

Top Investors: Bpifrance, Korea Investment Partners, Boehringer Ingelheim Venture Fund, Pureos Bioventures, Karista

Description:

Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.